Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Schnack C

Collect these papers and discover other ones on Labmeeting. Learn more.

Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.

+ cite this

+ View Abstract

Schnack C, Danzer KM, Hengerer B, and Gillardon F

Neuroscience 154(4):1450, 2008 Jul 17 - Who cited this? | PubMed ID: 18541383 | Fulltext

Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.

+ cite this

+ View Abstract

Krzyzanowska K, Zemany L, Krugluger W, Schernthaner GH, Mittermayer F, Schnack C, Rahman R, Brix J, Kahn BB, and Schernthaner G

Diabetologia 51(7):1115-22, 2008 Jul - Who cited this? | PubMed ID: 18437353 | Fulltext

Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays.

+ cite this

+ View Abstract

Schnack C, Hengerer B, and Gillardon F

Proteomics 8(10):1980-6, 2008 May - Who cited this? | PubMed ID: 18491313 | Fulltext

Reduced Basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.

+ cite this

+ View Abstract

Szendroedi J, Zwettler E, Schmid AI, Chmelik M, Pacini G, Kacerovsky G, Smekal G, Nowotny P, Wagner O, Schnack C, Schernthaner G, Klaushofer K, and Roden M

PLoS ONE 3(12):e3958, 2008 - Who cited this? | PubMed ID: 19093000 | Fulltext

Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.

+ cite this

+ View Abstract

Danzer KM, Schnack C, Sutcliffe A, Hengerer B, and Gillardon F

Journal of neurochemistry 103(6):2401-7, 2007 Dec - Who cited this? | PubMed ID: 17883396 | Fulltext

Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.

+ cite this

+ View Abstract

Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, and Schernthaner G

Atherosclerosis 189(1):236-40, 2006 Nov - Who cited this? | PubMed ID: 16414052 | Fulltext

High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism.

+ cite this

+ View Abstract

Krzyzanowska K, Schnack C, Mittermayer F, Kopp HP, Hofer M, Kann T, and Schernthaner G

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 113(8):430-4, 2005 Sep - Who cited this? | PubMed ID: 16151976 | Fulltext

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

+ cite this

+ View Abstract

Ludwig A, Schulte A, Schnack C, Hundhausen C, Reiss K, Brodway N, Held-Feindt J, and Mentlein R

Journal of neurochemistry 93(5):1293, 2005 Jun - Who cited this? | PubMed ID: 15934948 | Fulltext

Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.

+ cite this

+ View Abstract

Krzyzanowska K, Mittermayer F, Schnack C, Hofer M, Wolzt M, and Schernthaner G

European journal of clinical investigation 35(3):208-13, 2005 Mar - Who cited this? | PubMed ID: 15733076 | Fulltext

[Angiotensin II type-1 receptor antagonists and diabetes mellitus].

+ cite this

+ View Abstract

Schnack C and Schernthaner G

Wiener medizinische Wochenschrift (1946) 151(7-8):165-8, 2001 - Who cited this? | PubMed ID: 11450165 | Fulltext

Growth hormone replacement therapy is not associated with retinal changes.

+ cite this

+ View Abstract

Blank D, Riedl M, Reitner A, Schnack C, Schernthaner G, Clodi M, Frisch H, and Luger A

The Journal of clinical endocrinology and metabolism 85(2):634-6, 2000 Feb - Who cited this? | PubMed ID: 10690868 | Fulltext

Magnesium supplementation in type 2 diabetes.

+ cite this

Eibl N, Schnack C, and Schernthaner G

Diabetes care 21(11):2031-2, 1998 Nov - Who cited this? | PubMed ID: 9802766 | Fulltext

Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control.

+ cite this

+ View Abstract

Eibl N, Schnack C, Frank M, and Schernthaner G

Diabetes research and clinical practice 39(1):39-45, 1998 Jan - Who cited this? | PubMed ID: 9597373 | Fulltext

Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.

+ cite this

+ View Abstract

Schnack C, Hoffmann W, Hopmeier P, and Schernthaner G

Diabetologia 39(12):1611-6, 1996 Dec - Who cited this? | PubMed ID: 8960851 | Fulltext

Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus.

+ cite this

+ View Abstract

Equiluz-Bruck S, Schnack C, Kopp HP, and Schernthaner G

American journal of hypertension : journal of the American Society of Hypertension 9(11):1139-43, 1996 Nov - Who cited this? | PubMed ID: 8931842 | Fulltext

Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy.

+ cite this

+ View Abstract

Schnack C, Festa A, Schwarzmaier-D'Assié A, Haber P, and Schernthaner G

Nephron 74(2):395-400, 1996 - Who cited this? | PubMed ID: 8893162 | Fulltext

Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.

+ cite this

+ View Abstract

Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, and Schernthaner G

The American journal of medicine 98(5):469-75, 1995 May - Who cited this? | PubMed ID: 7733126 | Fulltext

Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.

+ cite this

+ View Abstract

Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, and Schernthaner G

Diabetes care 18(2):188-92, 1995 Feb - Who cited this? | PubMed ID: 7729296 | Fulltext

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.

+ cite this

+ View Abstract

Capek M, Schnack C, Ludvik B, Kautzky-Willer A, Banyai M, and Prager R

The Clinical investigator 72(12):961-6, 1994 Dec - Who cited this? | PubMed ID: 7711427 | Fulltext

Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients.

+ cite this

+ View Abstract

Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R, and Vukovich T

Thrombosis and haemostasis 71(6):692-7, 1994 Jun - Who cited this? | PubMed ID: 7974333 | Fulltext

Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.

+ cite this

+ View Abstract

Schnack C, Capek M, Banyai M, Kautzky-Willer A, Prager R, and Schernthaner G

Acta diabetologica 31(1):14-8, 1994 Apr - Who cited this? | PubMed ID: 8043891 | Fulltext

Apolipoprotein (a) levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type 2 diabetes mellitus.

+ cite this

+ View Abstract

Schnack C, Pietschmann P, Knöbl P, Schuller E, Prager R, and Schernthaner G

Nephron 66(3):273-7, 1994 - Who cited this? | PubMed ID: 8190178 | Fulltext

Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease.

+ cite this

+ View Abstract

Knöbl P, Pietschmann P, Schnack C, Prager R, and Schernthaner G

Wiener klinische Wochenschrift 106(23):728-32, 1994 - Who cited this? | PubMed ID: 7856176 | Fulltext

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

+ cite this

+ View Abstract

Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, and Müller M

Diabetologia 36(10):1045-50, 1993 Oct - Who cited this? | PubMed ID: 8243853 | Fulltext

Left ventricular diastolic impairment in type 1 diabetic patients with microalbuminuria.

+ cite this

+ View Abstract

Watschinger B, Brunner C, Wagner A, Schnack C, Prager R, Weissel M, and Burghuber OC

Nephron 63(2):145-51, 1993 - Who cited this? | PubMed ID: 8450905 | Fulltext

The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.

+ cite this

+ View Abstract

Vukovich T, Proidl S, Knöbl P, Teufelsbauer H, Schnack C, and Schernthaner G

Thrombosis and haemostasis 68(3):253-6, 1992 Sep 7 - Who cited this? | PubMed ID: 1440487 | Fulltext

Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.

+ cite this

+ View Abstract

Schnack C, Bauer I, Pregant P, Hopmeier P, and Schernthaner G

Diabetologia 35(1):77-9, 1992 Jan - Who cited this? | PubMed ID: 1541384 | Fulltext

Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.

+ cite this

+ View Abstract

Ludvik B, Lell B, Hartter E, Schnack C, and Prager R

Diabetes 40(12):1615-9, 1991 Dec - Who cited this? | PubMed ID: 1756902 | Fulltext

[Decreased plasma carnitine in Type I diabetes mellitus].

+ cite this

+ View Abstract

Pregant P, Schernthaner G, Legenstein E, Lienhart L, Bruck S, Schnack C, and Kaiser E

Klinische Wochenschrift 69(12):511-6, 1991 Aug 16 - Who cited this? | PubMed ID: 1921235 | Fulltext

Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.

+ cite this

+ View Abstract

Klauser R, Prager R, Gaube S, Gisinger C, Schnack C, Küenburg E, and Schernthaner G

Hypertension 17(1):15-21, 1991 Jan - Who cited this? | PubMed ID: 1824760 | Fulltext

[Effect of structured ambulatory training of patients with chronic respiratory tract diseases on the efficiency of long-term care].

+ cite this

+ View Abstract

Haber P, Sachs G, Röggla G, Spiess K, and Schnack C

Wiener klinische Wochenschrift 103(20):605-11, 1991 - Who cited this? | PubMed ID: 1763506 | Fulltext

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

+ cite this

+ View Abstract

Schnack C, Prager RJ, Winkler J, Klauser RM, Schneider BG, and Schernthaner G

Diabetes care 12(8):537-43, 1989 Sep - Who cited this? | PubMed ID: 2673693 | Fulltext

Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia.

+ cite this

+ View Abstract

Schnack C, Podolsky A, Watzke H, Schernthaner G, and Burghuber OC

The American review of respiratory disease 139(1):176-80, 1989 Jan - Who cited this? | PubMed ID: 2563217 | Fulltext

[Significance of arterial blood pressure for the development of microalbuminuria and retinopathy in type I diabetes mellitus].

+ cite this

+ View Abstract

Watschinger B, Schnack C, Bruck S, Stelzer N, Gisinger C, and Schernthaner G

Klinische Wochenschrift 66(21):1074-8, 1988 Nov 1 - Who cited this? | PubMed ID: 3236757 | Fulltext

Serum concentrations of laminin P1 in diabetics with advanced nephropathy.

+ cite this

+ View Abstract

Pietschmann P, Schernthaner G, Schnack CH, and Gaube S

Journal of clinical pathology 41(9):929-32, 1988 Sep - Who cited this? | PubMed ID: 3192751 | Fulltext

[The effect of information and relaxation groups on lung function and the psychophysical status of asthma patients].

+ cite this

Spiess K, Sachs G, Buchinger C, Röggla G, Schnack C, and Haber P

Praxis und Klinik der Pneumologie 42(7):641-4, 1988 Jul - Who cited this? | PubMed ID: 3054864 | Fulltext

Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.

+ cite this

+ View Abstract

Watzke H, Schernthaner G, Schnack C, Schwarz HP, Prskavec F, and Freyler H

Diabetes research (Edinburgh, Scotland) 7(4):197-200, 1988 Apr - Who cited this? | PubMed ID: 3402169 | Fulltext

Pituitary thyrotroph function and thyroid hormones in longstanding type-II diabetes mellitus before and after insulin treatment.

+ cite this

+ View Abstract

Schnack C and Schernthaner G

Experimental and clinical endocrinology 90(2):243-8, 1987 Sep - Who cited this? | PubMed ID: 3123258 | Fulltext

Prevalence of microalbuminuria in maturity onset primarily non-insulin-requiring diabetes mellitus: effect of disease duration, glycemic control, and mean systemic blood pressure.

+ cite this

+ View Abstract

Schnack C, Scheithauer W, Gisinger C, Winkler J, and Schernthaner G

The Journal of diabetic complications 1(4):132-6, 1987 - Who cited this? | PubMed ID: 2969386 | Fulltext

Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

+ cite this

+ View Abstract

Schnack C, Röggla G, Luger A, and Schernthaner G

European journal of clinical pharmacology 30(4):417-9, 1986 - Who cited this? | PubMed ID: 3527720 | Fulltext

Two techniques for administering a paste anthelmintic to cattle.

+ cite this

Schnack CL, Boysen DL, and Henrichsen KA

Veterinary medicine, small animal clinician : VM, SAC 72(12):1872-3, 1977 Dec - Who cited this? | PubMed ID: 245210 | Fulltext

Search Google Scholar for Schnack C

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!